E-LIB Suche - Ergebnisse für: Budd Haeberlein, S

1

Japanese Subgroup Analyses from EMERGE and ENGAGE, Phase 3 ..:

Toda, Y. ; Iwatsubo, T. ; Nakamura, Y....
The Journal of Prevention of Alzheimer's Disease. , 2024

Link: https://doi.org/10.14283..

2

Investigating Partially Discordant Results in Phase 3 Studi..:

Mallinckrodt, C. ; Tian, Y. ; Aisen, P.S....
The Journal Of Prevention of Alzheimer's Disease. , 2023

Link: https://doi.org/10.14283..

3

Two Randomized Phase 3 Studies of Aducanumab in Early Alzhe..:

Budd Haeberlein, S. ; Aisen, P.S. ; Barkhof, F....
The Journal of Prevention of Alzheimer's Disease. , 2022

Link: https://doi.org/10.14283..

4

24-MONTH ANALYSIS FROM PRIME, A PHASE 1B STUDY IN PATIENTS ..:

von Rosenstiel, P ; Gheuens, S ; O'Gorman, J...
Innovation in Aging. 2 (2018) suppl_1 - p. 135-135 , 2018

Link: https://doi.org/10.1093/..

5

Excitotoxicity in Neurodegenerative Disease:

, In: Encyclopedia of Neuroscience,

Budd Haeberlein, S.L. ; Lipton, S.A. - p. 77-86 , 2009

Link: https://doi.org/10.1016/..

6

Investigating Partially Discordant Results in Phase 3 Studi..:

Mallinckrodt, C ; Tian, Y ; Aisen, PS...
https://discovery.ucl.ac.uk/id/eprint/10163690/1/jpad.2023.6.pdf. , 2023

Link: https://discovery.ucl.ac..

7

Two Randomized Phase 3 Studies of Aducanumab in Early Alzhe..:

Budd Haeberlein, S ; Aisen, PS ; Barkhof, F...
https://discovery.ucl.ac.uk/id/eprint/10146033/1/BuddHaeberlein2022_Article_TwoRandomizedPhase3StudiesOfAd.pdf. , 2022

Link: https://discovery.ucl.ac..

8

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies ..:

Salloway, S ; Chalkias, S ; Barkhof, F...
https://discovery.ucl.ac.uk/id/eprint/10140420/1/Barkhof_jamaneurology_salloway_2021_oi_210073_1637252173.40946.pdf. , 2021

Link: https://discovery.ucl.ac..

9

Harmonization of tau‐PET in Alzheimer's disease: comparison..:

Leuzy, Antoine ; Dore, Vincent ; Raket, Lars Lau...
Alzheimer's & Dementia. 19 (2023) S14 - p. , 2023

Link: https://doi.org/10.1002/..

10

Harmonization of tau‐PET in Alzheimer's disease: comparison..:

Leuzy, Antoine ; Dore, Vincent ; Raket, Lars Lau...
Alzheimer's & Dementia. 19 (2023) S10 - p. , 2023

Link: https://doi.org/10.1002/..

11

Baseline Characteristics From ENGAGE and EMERGE: Two Phase ..:

von Hehn, Christian ; von Rosenstiel, Philipp ; Tian, Ying...
Neurology. 92 (2019) 15_supplement - p. , 2019

Link: https://doi.org/10.1212/..

12

Plasma Biomarkers of AD Emerging as Essential Tools for Dru..:

Bateman, R ; Blennow, K ; Doody, R...
https://discovery.ucl.ac.uk/id/eprint/10075238/3/Zetterberg_Plasma%20Biomarkers%20of%20AD%20Emerging%20as%20Essential%20Tools%20for%20Drug%20Development.%20An%20EU%20US%20CTAD%20Task%20Force%20Report_AAM.pdf. , 2019

Link: https://discovery.ucl.ac..

13

The National Institute on Aging and the Alzheimer's Associa..:

Knopman, David S. ; Haeberlein, Samantha Budd ; Carrillo, Maria C....
Alzheimer's & Dementia. 14 (2018) 4 - p. 563-575 , 2018

Link: https://doi.org/10.1016/..

14

The National Institute on Aging and the Alzheimer's Associa..:

Knopman, David S ; Haeberlein, Samantha Budd ; Carrillo, Maria C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747694/. , 2018

Link: http://www.ncbi.nlm.nih...

15

Genome-Wide Association Studies of ARIA From the Aducanumab..:

Loomis, Stephanie J. ; Miller, Ryan ; Castrillo-Viguera, Carmen...
Neurology. 102 (2024) 3 - p. , 2024

Link: https://doi.org/10.1212/..